共 442 条
[1]
Guillevin L(2013)2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides Arthritis Rheum 65 1-11
[2]
Hagen EC(2005)Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg-Strauss syndrome Arthritis Rheum 52 2926-2935
[3]
Hoffman GS(2012)Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes J Allergy Clin Immunol 130 607-12.e9
[4]
Jayne DR(2005)What is known about the epidemiology of the vasculitides? Best Pract Res Clin Rheumatol 19 191-207
[5]
Kallenberg CGM(2013)Eosinophilic granulomatosis with polyangiitis (Churg–Strauss): state of the art Allergy 68 261-273
[6]
Lamprecht P(1951)Allergic granulomatosis, allergic angiitis, and periarteritis nodosa Am J Pathol 27 277-301
[7]
Sinico RA(1995)Vasculitides associated with infections, immunization, and antimicrobial drugs Clin Infect Dis 20 1010-1036
[8]
Di Toma L(2007)HLA–DRB4 as a genetic risk factor for Churg–Strauss syndrome Arthritis Rheum 56 3159-3166
[9]
Maggiore U(2011)Both Th2 and Th17 responses are involved in the pathogenesis of Churg–Strauss syndrome Clin Exp Rheumatol 29 S23-S34
[10]
Bottero P(2010)Increased levels of BLyS and sVCAM-1 in anti-neutrophil cytoplasmatic antibody (ANCA)-associated vasculitides (AAV) Clin Exp Rheumatol 28 62-66